Podcast 6 Feb 2026How Eli Lilly’s biotech collaboration model is rewriting early-stage innovation Today, we’re joined by Thomas Hopkins, Vice President and Head of ExploR&D at Eli Lilly. February 6, 2026 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 30 Jan 2026Building a smart oncology pipeline with Cumulus Oncology Today, our guest is Dr. Clare Wareing, Founder and CEO of Cumulus Oncology, who joins us from Edinburgh. January 30, 2026 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 23 Jan 2026Top 5 trends that will drive biopharma in the next decade with Tim Opler Today, we’re thrilled to have Tim Opler, a leading voice in biotech investment banking. January 23, 2026 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 16 Jan 2026Labiotech’s 15 biopharma companies to watch in 2026 January 16, 2026 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 9 Jan 2026M Ventures: pharma CVC and biotech innovation in 2026 Today, we’re joined by Hakan Goker, Managing Director at M Ventures, the strategic corporate venture capital arm of Merck KGaA. January 9, 2026 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 19 Dec 2025Johnson & Johnson’s hematology portfolio: breakthroughs to watch Today’s guest is J&J’s Ester in t’Groen and we will discuss what’s next for J&J in hematology in 2026—including some exciting readouts. December 19, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 12 Dec 2025Tackling pulmonary fibrosis: Boehringer Ingelheim’s new drug + AI approach In this episode we sit down with Martin Beck, Senior Vice President and Head of the Inflammation Business Unit at Boehringer Ingelheim. December 12, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 5 Dec 2025Cracking Cancer’s Code: Transforming Research with Novel Cancer Models This week’s guest is Mark Lanasa of BeOne Medicines and we will discuss their novel cancer models and unique in-house R&D approach. December 5, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 28 Nov 2025Curing cancer: Daiichi Sankyo’s ambitious ADC approach In today’s episode, Dr. Markus Kosch, Head of the EU Oncology Business Division at Daiichi Sankyo will discuss the company’s approach November 28, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 21 Nov 2025How to succeed at BIO-Europe: DISCO Pharma takes us behind the scenes Labiotech followed one biotech heading into their first BIO-Europe partnering conference: cancer therapeutics company DISCO Pharma. November 21, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 14 Nov 2025Meet Fusix Biotech: 2025 BIO-Europe Startup Spotlight champion revolutionizing oncology Labiotech sat down with Jennifer Altomonte, co-founder of the BioEurope Startup Spotlight finalist, Fusix Biotech, who discussed Fusix’s cancer platform technology. November 14, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 7 Nov 2025Next‑generation UTI diagnostics: delivering results in just 35 minutes Llusern’s Lodestar DX aims to improve urinary tract infection diagnostics. It has created a test that detects pathogens in just 35 minutes, no lab required. November 7, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More